Product Profile

Keeogo / Keeogo+

By B-Temia

Powered smart orthosis / dermoskeleton for walking assistance, rehabilitation and community mobility.

Status Region-Limited
Product Type Powered
Body Area Lower Limb
Use Case Rehabilitation, Walking & Mobility
Region-Limited Quote-Based Strong sources

Product Overview

Keeogo is B-TEMIA’s powered smart orthosis for walking assistance in rehabilitation and community settings. B-TEMIA states that it is available for sale or rental in Canada; U.S. use is limited to research or investigational settings, not commercial sale. The U.S. FDA 510(k) indication is prescription, supervised rehabilitation for a defined stroke population; it does not establish ordinary U.S. retail availability or global approval. Canadian access begins with clinical screening through a certified network.

Positioning & Buyer Fit

Positioning

Region-limited powered knee and lower-limb walking assistance: Canadian sale or rental; United States investigational/research use only.

Best For

Canadian users and rehabilitation providers evaluating Keeogo through the manufacturer's screening and certified-clinic pathway; U.S. access is limited to research or investigational use.

Lower-limb support
Powered mobility support
Assistive wearable robotics

Use Case & Product Classification

Body Area
Product Type
Industry / Setting
Device Type

Powered knee orthosis / dermoskeleton

Claims & Evidence

Technical Highlights
  • Powered
Sizing / Fit

Keeogo FAQ: height above 5 ft (155 cm) and waist 26-42 in (about 66-107 cm); the device is mechanically adjusted and software-tuned for each user. No current public maximum body-weight limit was located. Independent community use requires some walking ability and independent balance.

Independent evidence

A 2025 peer-reviewed single-arm pilot studied 13 adults aged 51-89 with multimorbidity using Keeogo-assisted rehabilitation and reported short-term functional mobility improvements; this is early evidence, not definitive comparative efficacy.

Certification & Regulatory Notes

Regulatory Status

United States: FDA 510(k) K201539 for the Keeogo Dermoskeleton System, decision date 9 September 2020 (substantially equivalent).

Notes

FDA 510(k) K201539 indication: prescription use to assist ambulatory function in rehabilitation settings under trained healthcare professional supervision for individuals with stroke who have gait deficits, hip strength MMT ≥3 and knee strength MMT ≥2, and can stand and initiate gait without assistance. The trained professional must complete device training before fitting and tuning. This is U.S.-specific and does not imply commercial sale.

Pricing & Commercial Access

Pricing Quote-based

Contact manufacturer for current pricing

Pricing Status

Quote-Based

Pricing Model

Quote Based

Currency

Not specified

Price Period

Unknown

Product sourcing support Need help assessing this product or comparing alternatives?

Tell us about your task, users, industry and region. We can help identify relevant products, suppliers and practical next steps.

Discuss your requirements

Sources & External Links

Product profiles are compiled from official and public sources. Pricing, availability, performance claims and deployment requirements may vary by region, configuration and distributor.
Stay Updated

Follow exoskeleton product launches, events and market notes

Get curated updates on new products, supplier activity, buyer guides and industry developments.

Join newsletter